Fennec Pharmaceuticals Inc (FRX.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 12,462 | 9,652 | 8,751 | 7,925 | 6,974 |
| Cost of Goods | 660 | 967 | 373 | 669 | 1,357 |
| Gross Profit | 11,802 | 8,685 | 8,378 | 7,256 | 5,617 |
| Operating Expenses | 12,003 | 11,417 | 9,199 | 8,215 | 10,840 |
| Operating Income | -201 | -2,732 | -821 | -959 | -5,223 |
| Interest Expense | 586 | 594 | 592 | 966 | 1,025 |
| Other Income | 149 | 174 | 248 | 305 | 513 |
| Pre-tax Income | -638 | -3,152 | -1,165 | -1,620 | -5,735 |
| Net Income Continuous | -638 | -3,152 | -1,165 | -1,985 | -5,735 |
| Net Income | $-638 | $-3,152 | $-1,165 | $-1,985 | $-5,735 |
| EPS Basic Total Ops | -0.02 | -0.11 | -0.04 | -0.06 | -0.21 |
| EPS Basic Continuous Ops | -0.02 | -0.11 | -0.04 | -0.06 | -0.21 |
| EPS Diluted Total Ops | -0.02 | -0.11 | -0.04 | -0.06 | -0.21 |
| EPS Diluted Continuous Ops | -0.02 | -0.11 | -0.04 | -0.06 | -0.21 |
| EBITDA(a) | $-26 | $-2,533 | $-547 | $-628 | $-4,685 |